Cresco Labs Inc. (CSE:CL)
1.120
-0.160 (-12.50%)
May 15, 2026, 3:59 PM EST
Cresco Labs Revenue
Cresco Labs had revenue of $151.33M USD in the quarter ending March 31, 2026, a decrease of -7.31%. This brings the company's revenue in the last twelve months to $641.42M, down -9.46% year-over-year. In the year 2025, Cresco Labs had annual revenue of $655.85M, down -9.46%.
Revenue (ttm)
$641.42M
Revenue Growth
-9.46%
P/S Ratio
0.46
Revenue / Employee
$221.18K
Employees
2,900
Market Cap
414.22M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 655.85M | -68.50M | -9.46% |
| Dec 31, 2024 | 724.34M | -31.71M | -4.19% |
| Dec 31, 2023 | 756.06M | -68.87M | -8.35% |
| Dec 31, 2022 | 824.93M | 19.25M | 2.39% |
| Dec 31, 2021 | 805.68M | 342.60M | 73.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Verano Holdings | 1.14B |
| Knight Therapeutics | 510.45M |
| Aurora Cannabis | 373.12M |
| TerrAscend | 365.43M |
| Canopy Growth | 278.39M |
| DRI Healthcare Trust | 275.81M |
| Organigram Global | 274.19M |
| Auxly Cannabis Group | 158.57M |
Cresco Labs News
- 8 days ago - Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety - Business Wire
- 11 days ago - Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiatives - Business Wire
- 14 days ago - Cresco Labs Opens Sunnyside Aberdeen, Marking Second Ohio Dispensary Opening in a Month - Business Wire
- 14 days ago - Top Marijuana Stocks and Investment Outlook 2026 - MarijuanaStocks
- 19 days ago - Marijuana Stocks: Industry Growth, Rescheduling Impact, and Outlook - MarijuanaStocks
- 25 days ago - Cresco Labs says rescheduling medical cannabis ‘a long-overdue step’ - TheFly
- 25 days ago - Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients - Business Wire
- 26 days ago - Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026 - Business Wire